Cargando…

Improving patient-reported measures in oncology: a payer call to action

Despite rising interest in integrating the patient voice in value-based payment (VBP) models for oncology, barriers persist to implementing patient-reported measures (PRMs), including patient-reported performance measures (PR-PMs). This article describes the landscape of oncology PRMs and PR-PMs, id...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Theresa, Valuck, Tom, Perkins, Brittany, Riposo, Jacqlyn, Patel, Palak, Westrich, Kimberly, Basch, Ethan, McClellan, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394208/
https://www.ncbi.nlm.nih.gov/pubmed/33103618
http://dx.doi.org/10.18553/jmcp.2020.20313
_version_ 1785083318413295616
author Schmidt, Theresa
Valuck, Tom
Perkins, Brittany
Riposo, Jacqlyn
Patel, Palak
Westrich, Kimberly
Basch, Ethan
McClellan, Mark
author_facet Schmidt, Theresa
Valuck, Tom
Perkins, Brittany
Riposo, Jacqlyn
Patel, Palak
Westrich, Kimberly
Basch, Ethan
McClellan, Mark
author_sort Schmidt, Theresa
collection PubMed
description Despite rising interest in integrating the patient voice in value-based payment (VBP) models for oncology, barriers persist to implementing patient-reported measures (PRMs), including patient-reported performance measures (PR-PMs). This article describes the landscape of oncology PRMs and PR-PMs, identifies implementation barriers, and recommends solutions for public and private payers to accelerate the appropriate use of PRMs in oncology VBP programs. Our research used a multimethod approach that included a literature review, landscape scan, stakeholder interviews and survey, and a multistakeholder roundtable. The literature review and landscape scan found that limited oncology-specific PR-PMs are available and some are already used in VBP programs. Diverse stakeholder perspectives provided insight into filling current gaps in measurement and removing implementation barriers, such as limited relevance of existing PRMs and PR-PMs for oncology; methodological challenges; patient burden and survey fatigue; and provider burden from resource constraints, competing priorities, and insufficient incentives. Key recommendations include: (a) identify or develop meaningful measures that fill gaps, engaging patients throughout measure and program development and evaluation; (b) design programs that include scientifically sound measures standardized to reduce patient and provider burden while supporting care; and (c) engage providers using a stepwise approach that offers resources and incentives to support implementation.
format Online
Article
Text
id pubmed-10394208
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-103942082023-08-03 Improving patient-reported measures in oncology: a payer call to action Schmidt, Theresa Valuck, Tom Perkins, Brittany Riposo, Jacqlyn Patel, Palak Westrich, Kimberly Basch, Ethan McClellan, Mark J Manag Care Spec Pharm Viewpoints Despite rising interest in integrating the patient voice in value-based payment (VBP) models for oncology, barriers persist to implementing patient-reported measures (PRMs), including patient-reported performance measures (PR-PMs). This article describes the landscape of oncology PRMs and PR-PMs, identifies implementation barriers, and recommends solutions for public and private payers to accelerate the appropriate use of PRMs in oncology VBP programs. Our research used a multimethod approach that included a literature review, landscape scan, stakeholder interviews and survey, and a multistakeholder roundtable. The literature review and landscape scan found that limited oncology-specific PR-PMs are available and some are already used in VBP programs. Diverse stakeholder perspectives provided insight into filling current gaps in measurement and removing implementation barriers, such as limited relevance of existing PRMs and PR-PMs for oncology; methodological challenges; patient burden and survey fatigue; and provider burden from resource constraints, competing priorities, and insufficient incentives. Key recommendations include: (a) identify or develop meaningful measures that fill gaps, engaging patients throughout measure and program development and evaluation; (b) design programs that include scientifically sound measures standardized to reduce patient and provider burden while supporting care; and (c) engage providers using a stepwise approach that offers resources and incentives to support implementation. Academy of Managed Care Pharmacy 2021-01 /pmc/articles/PMC10394208/ /pubmed/33103618 http://dx.doi.org/10.18553/jmcp.2020.20313 Text en Copyright © 2021, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Viewpoints
Schmidt, Theresa
Valuck, Tom
Perkins, Brittany
Riposo, Jacqlyn
Patel, Palak
Westrich, Kimberly
Basch, Ethan
McClellan, Mark
Improving patient-reported measures in oncology: a payer call to action
title Improving patient-reported measures in oncology: a payer call to action
title_full Improving patient-reported measures in oncology: a payer call to action
title_fullStr Improving patient-reported measures in oncology: a payer call to action
title_full_unstemmed Improving patient-reported measures in oncology: a payer call to action
title_short Improving patient-reported measures in oncology: a payer call to action
title_sort improving patient-reported measures in oncology: a payer call to action
topic Viewpoints
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394208/
https://www.ncbi.nlm.nih.gov/pubmed/33103618
http://dx.doi.org/10.18553/jmcp.2020.20313
work_keys_str_mv AT schmidttheresa improvingpatientreportedmeasuresinoncologyapayercalltoaction
AT valucktom improvingpatientreportedmeasuresinoncologyapayercalltoaction
AT perkinsbrittany improvingpatientreportedmeasuresinoncologyapayercalltoaction
AT riposojacqlyn improvingpatientreportedmeasuresinoncologyapayercalltoaction
AT patelpalak improvingpatientreportedmeasuresinoncologyapayercalltoaction
AT westrichkimberly improvingpatientreportedmeasuresinoncologyapayercalltoaction
AT baschethan improvingpatientreportedmeasuresinoncologyapayercalltoaction
AT mcclellanmark improvingpatientreportedmeasuresinoncologyapayercalltoaction